Cytogenetic and molecular genetic study on granular cell glioblastoma: a case report
- PMID: 23058249
- DOI: 10.1016/j.humpath.2012.07.022
Cytogenetic and molecular genetic study on granular cell glioblastoma: a case report
Abstract
Granular cell astrocytoma is a rare infiltrative malignant glioma with prominent granular cell change. Granular cell astrocytomas are biologically aggressive compared with conventional infiltrating astrocytomas of similar grades, but their genetic alterations are poorly known. We report a case of granular cell glioblastoma and its genetic and molecular features. Histologically, the tumor not only showed features typical of granular cell astrocytoma but also demonstrated frequent mitoses, pseudopalisading necrosis, and vascular endothelial hyperplasia, compatible with glioblastoma. Array-based comparative genomic hybridization and focused molecular genetic analyses demonstrated gain of chromosome 7; losses of chromosome 1p, 8p, 9p, 10, 13q, and 22q; amplification of epidermal growth factor receptor; and homozygous deletion of CDKN2A as well as MGMT promoter methylation. However, neither isocitrate dehydrogenase 1 mutation nor codeletion of 1p/19q was found. Our results indicate that granular cell glioblastomas, despite having its peculiar granular cell changes, share common molecular genetic features with conventional glioblastoma, especially the classical subtype.
Copyright © 2013 Elsevier Inc. All rights reserved.
Comment in
-
Demystifying the molecular signature of glioblastoma multiforme arising in its rare morphological variants.Hum Pathol. 2013 May;44(5):934-5. doi: 10.1016/j.humpath.2012.11.022. Hum Pathol. 2013. PMID: 23601920 No abstract available.
-
Demystifying the molecular signature of glioblastoma multiforme arising in its rare morphologic variants--reply.Hum Pathol. 2013 May;44(5):935. doi: 10.1016/j.humpath.2013.02.001. Hum Pathol. 2013. PMID: 23601921 No abstract available.
Similar articles
-
Prognostic significance of molecular markers and extent of resection in primary glioblastoma patients.Clin Cancer Res. 2009 Nov 1;15(21):6683-93. doi: 10.1158/1078-0432.CCR-08-2801. Epub 2009 Oct 27. Clin Cancer Res. 2009. PMID: 19861461
-
Molecular predictors of progression-free and overall survival in patients with newly diagnosed glioblastoma: a prospective translational study of the German Glioma Network.J Clin Oncol. 2009 Dec 1;27(34):5743-50. doi: 10.1200/JCO.2009.23.0805. Epub 2009 Oct 5. J Clin Oncol. 2009. PMID: 19805672
-
Genetic analyses for predictors of radiation response in glioblastoma.Int J Radiat Oncol Biol Phys. 2005 Nov 1;63(3):704-10. doi: 10.1016/j.ijrobp.2005.03.059. Epub 2005 Jun 22. Int J Radiat Oncol Biol Phys. 2005. PMID: 15978739
-
Loss of heterozygosity analysis in malignant gliomas.Brain Tumor Pathol. 2011 Jul;28(3):191-6. doi: 10.1007/s10014-011-0038-0. Epub 2011 Jun 1. Brain Tumor Pathol. 2011. PMID: 21629980 Review.
-
Genetic alterations associated with glioma progression.Verh Dtsch Ges Pathol. 1994;78:43-7. Verh Dtsch Ges Pathol. 1994. PMID: 7534015 Review.
Cited by
-
Granular cell astrocytoma: an aggressive IDH-wildtype diffuse glioma with molecular genetic features of primary glioblastoma.Brain Pathol. 2019 Mar;29(2):193-204. doi: 10.1111/bpa.12657. Epub 2018 Oct 10. Brain Pathol. 2019. PMID: 30222900 Free PMC article.
-
Diagnostic test accuracy and cost-effectiveness of tests for codeletion of chromosomal arms 1p and 19q in people with glioma.Cochrane Database Syst Rev. 2022 Mar 2;3(3):CD013387. doi: 10.1002/14651858.CD013387.pub2. Cochrane Database Syst Rev. 2022. PMID: 35233774 Free PMC article.
-
Expression and clinical significance of TIMELESS in glioma.Int J Clin Exp Pathol. 2021 Sep 15;14(9):938-955. eCollection 2021. Int J Clin Exp Pathol. 2021. PMID: 34646412 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous